These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
504 related articles for article (PubMed ID: 32119176)
1. Epstein-Barr virus-positive gastric cancer involves enhancer activation through activating transcription factor 3. Asakawa Y; Okabe A; Fukuyo M; Li W; Ikeda E; Mano Y; Funata S; Namba H; Fujii T; Kita K; Matsusaka K; Kaneda A Cancer Sci; 2020 May; 111(5):1818-1828. PubMed ID: 32119176 [TBL] [Abstract][Full Text] [Related]
2. Activation of EHF via STAT3 phosphorylation by LMP2A in Epstein-Barr virus-positive gastric cancer. Li W; Okabe A; Usui G; Fukuyo M; Matsusaka K; Rahmutulla B; Mano Y; Hoshii T; Funata S; Hiura N; Fukayama M; Tan P; Ushiku T; Kaneda A Cancer Sci; 2021 Aug; 112(8):3349-3362. PubMed ID: 34014591 [TBL] [Abstract][Full Text] [Related]
3. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival. Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528 [TBL] [Abstract][Full Text] [Related]
4. RNA Sequencing Analyses of Gene Expression during Epstein-Barr Virus Infection of Primary B Lymphocytes. Wang C; Li D; Zhang L; Jiang S; Liang J; Narita Y; Hou I; Zhong Q; Zheng Z; Xiao H; Gewurz BE; Teng M; Zhao B J Virol; 2019 Jul; 93(13):. PubMed ID: 31019051 [TBL] [Abstract][Full Text] [Related]
5. Olaparib-induced Apoptosis Through EBNA1-ATR-p38 MAPK Signaling Pathway in Epstein-Barr Virus-positive Gastric Cancer Cells. Moon SH; Park NS; Noh MH; Kim YS; Cheong SH; Hur DY Anticancer Res; 2022 Jan; 42(1):555-563. PubMed ID: 34969765 [TBL] [Abstract][Full Text] [Related]
6. Regulation of tumour related genes by dynamic epigenetic alteration at enhancer regions in gastric epithelial cells infected by Epstein-Barr virus. Okabe A; Funata S; Matsusaka K; Namba H; Fukuyo M; Rahmutulla B; Oshima M; Iwama A; Fukayama M; Kaneda A Sci Rep; 2017 Aug; 7(1):7924. PubMed ID: 28801683 [TBL] [Abstract][Full Text] [Related]
7. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer. Liang Q; Yao X; Tang S; Zhang J; Yau TO; Li X; Tang CM; Kang W; Lung RW; Li JW; Chan TF; Xing R; Lu Y; Lo KW; Wong N; To KF; Yu C; Chan FK; Sung JJ; Yu J Gastroenterology; 2014 Dec; 147(6):1350-62.e4. PubMed ID: 25173755 [TBL] [Abstract][Full Text] [Related]
8. Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma. Sivachandran N; Dawson CW; Young LS; Liu FF; Middeldorp J; Frappier L J Virol; 2012 Jan; 86(1):60-8. PubMed ID: 22013060 [TBL] [Abstract][Full Text] [Related]
9. Enhancer Control of MicroRNA miR-155 Expression in Epstein-Barr Virus-Infected B Cells. Wood CD; Carvell T; Gunnell A; Ojeniyi OO; Osborne C; West MJ J Virol; 2018 Oct; 92(19):. PubMed ID: 30021904 [TBL] [Abstract][Full Text] [Related]
11. The Epstein-Barr Virus Enhancer Interaction Landscapes in Virus-Associated Cancer Cell Lines. Ding W; Wang C; Narita Y; Wang H; Leong MML; Huang A; Liao Y; Liu X; Okuno Y; Kimura H; Gewurz B; Teng M; Jin S; Sato Y; Zhao B J Virol; 2022 Sep; 96(18):e0073922. PubMed ID: 36094314 [TBL] [Abstract][Full Text] [Related]
12. B Cell-Specific Transcription Activator PAX5 Recruits p300 To Support EBNA1-Driven Transcription. Liu CD; Lee HL; Peng CW J Virol; 2020 Mar; 94(7):. PubMed ID: 31941781 [TBL] [Abstract][Full Text] [Related]
13. ARID1A deficiency in EBV-positive gastric cancer is partially regulated by EBV-encoded miRNAs, but not by DNA promotor hypermethylation. Kase K; Saito M; Nakajima S; Takayanagi D; Saito K; Yamada L; Ashizawa M; Nakano H; Hanayama H; Onozawa H; Okayama H; Endo H; Fujita S; Sakamoto W; Saze Z; Momma T; Mimura K; Ohki S; Shiraishi K; Kohno T; Kono K Carcinogenesis; 2021 Feb; 42(1):21-30. PubMed ID: 33196828 [TBL] [Abstract][Full Text] [Related]
14. Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer. Zhao J; Jin H; Cheung KF; Tong JH; Zhang S; Go MY; Tian L; Kang W; Leung PP; Zeng Z; Li X; To KF; Sung JJ; Yu J Cancer; 2012 Feb; 118(4):924-36. PubMed ID: 21717425 [TBL] [Abstract][Full Text] [Related]
15. Galectin-9 Facilitates Epstein-Barr Virus Latent Infection and Lymphomagenesis in Human B Cells. Xu JX; Zhang R; Huang DJ; Tang Y; Ping LQ; Huang BJ; Huang HQ; Busson P; Li J Microbiol Spectr; 2023 Feb; 11(1):e0493222. PubMed ID: 36622166 [TBL] [Abstract][Full Text] [Related]
16. Transcriptome-wide analysis of alternative RNA splicing events in Epstein-Barr virus-associated gastric carcinomas. Armero VES; Tremblay MP; Allaire A; Boudreault S; Martenon-Brodeur C; Duval C; Durand M; Lapointe E; Thibault P; Tremblay-Létourneau M; Perreault JP; Scott MS; Bisaillon M PLoS One; 2017; 12(5):e0176880. PubMed ID: 28493890 [TBL] [Abstract][Full Text] [Related]
17. TET2 functions as a resistance factor against DNA methylation acquisition during Epstein-Barr virus infection. Namba-Fukuyo H; Funata S; Matsusaka K; Fukuyo M; Rahmutulla B; Mano Y; Fukayama M; Aburatani H; Kaneda A Oncotarget; 2016 Dec; 7(49):81512-81526. PubMed ID: 27829228 [TBL] [Abstract][Full Text] [Related]
18. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter. Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr Virus Episome Physically Interacts with Active Regions of the Host Genome in Lymphoblastoid Cells. Wang L; Laing J; Yan B; Zhou H; Ke L; Wang C; Narita Y; Zhang Z; Olson MR; Afzali B; Zhao B; Kazemian M J Virol; 2020 Nov; 94(24):. PubMed ID: 32999023 [TBL] [Abstract][Full Text] [Related]
20. EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein-Barr virus-associated gastric cancer. Soldan SS; Anderson EM; Frase DM; Zhang Y; Caruso LB; Wang Y; Deakyne JS; Gewurz BE; Tempera I; Lieberman PM; Messick TE Gastric Cancer; 2021 Sep; 24(5):1076-1088. PubMed ID: 33929613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]